Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology

Product Image
Product Description

Leveraging TH17 pathway biomarkers in chronic inflammatory diseases is highly challenging due to their low abundance. Recent research shows that detection and monitoring of TH17 cytokine concentrations can provide insights into disease progression and thus, cytokines have become attractive biomarkers and candidates for targeted therapies. These biomarkers are key members of the IL-17 signaling pathway, serving to induce and mediate pro-inflammatory responses in numerous immune mediated diseases, such as Rheumatoid Arthritis and asthma, among others.

Powered by Singulex; high-definition Erenna® technology’s powerful suite of TH17 pathway immunoassay kits, with LLoQ down to the sub picogram levels, offers researchers unique and novel insights, enabling quicker and more confident decision making. To Learn More:  Download TH17 Pathway Solutions!

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.

Watch High-Definition Erenna® Technology Video >>



Download TH17 Pathway Solutions!

Product Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology
Company Singulex
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

1701 Harbor Bay Parkway, Alameda, California, 94502, USA

Tel: +1.888.995.6955
Fax: +1.510.995.9090

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.


SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos